The Trump administration has announced an additional $250 million in aid to the Philippines, aimed at combating tuberculosis, improving maternal health, and addressing emerging disease threats. U.S. Secretary of State Marco Rubio revealed the funding on Thursday, highlighting the initiative as part of President Donald Trump’s new foreign aid strategy.
This announcement follows the $63 million commitment made during Trump’s meeting with Philippine President Ferdinand Marcos Jr. at the White House in July. Rubio emphasized that the aid reflects the “comprehensive bond between the United States and the Philippines” and showcases a more “efficient, time-limited, and narrowly targeted” America First approach to foreign assistance.
The Philippine embassy in Washington expressed appreciation for the aid but offered no further comments. The pledge underscores Washington’s continued strategic interest in strengthening bilateral ties with Manila while shifting away from traditional aid models such as USAID.
The Trump administration has consistently sought to reduce foreign assistance, attempting to withhold billions of dollars allocated by Congress as part of its broader “America First” policy. Despite these efforts, lawmakers, led by Republicans, have set aside billions in foreign aid funding, including $11 billion that must be allocated before the September 30 deadline.
After facing lawsuits, the administration agreed to release $6.5 billion in aid but continues to fight in court to block another $4 billion. The dispute is currently under review by the U.S. Supreme Court.
The latest pledge to the Philippines highlights Trump’s direct aid strategy, which prioritizes targeted investments in key areas while scaling back traditional multilateral pipelines. As Washington redefines its foreign assistance framework, the Philippines emerges as a key partner in regional health and security cooperation.


U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Qatar Condemns Drone Strike as Iran Conflict Threatens Gulf Shipping and Global Markets
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Why the future of marijuana legalization remains hazy despite high public support
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Trump-Xi Summit Sparks Renewed Hope for Americans Detained in China
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Trump Says Iran Ceasefire ‘On Life Support’ as Oil Prices Surge Above $104
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Rubio Discusses Iran Crisis and Strait of Hormuz Disruptions With UK and Australia
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
EU Approves New Sanctions on Israeli Settlers and Hamas Leaders 



